Case file

ReLife cough syrup (Shape Pharma)

Last checked 19 September 2026. Some details are still being verified.

ReLife cough syrup (Shape Pharma)
Recalled · production suspendedShape Pharma · Gujarat (district:, being verified

ReLife is a cough syrup made by Shape Pharma in Gujarat that was found contaminated with diethylene glycol during the October 2025 investigations that followed the Coldrif deaths. It was named alongside Coldrif and Respifresh TR in WHO Medical Product Alert N°5/2025 on 13 October 2025. Gujarat suspended production at Shape Pharma, Telangana's Drugs Control Administration issued a public alert about the syrup, and Maharashtra's FDA issued a prohibition order on DEG-contaminated syrups. The WHO found no evidence that the product had been exported.

Status as of 19 September 2026

Primary government sourceTier 1: government primary source

Maharashtra FDA: prohibition order on cough syrups with diethylene glycol

CDSCO and state drug controllers

View original document

Scope. A record here does not by itself mean a product or company is unsafe or banned today. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

Affected products and batches

ProductBatchNote
ReLife Syrup, being verifiedDiethylene glycol detected; percentage not in our sources

Current status

Recalled; production suspended by Gujarat; covered by state prohibition orders as of 19 Sep 2026. No deaths have been publicly attributed specifically to ReLife in our sources.

What to do if you have this product

Step 1

Do not use ReLife syrup of any batch; return it to the pharmacy.

Step 2

Seek immediate care for a child with reduced urine, vomiting or drowsiness after taking any cough syrup.

Step 3

Do not give cough syrups to children under two.

Official sources and primary records